Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP214 in Patients Undergoing Cardiac Surgery
NCT00903604Phase 2Completed
- Sponsor
- Action Pharma A/S
- Start
- May 2009
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney injury (AKI) comparing AP214 Arm with Placebo Arm (2 arms). Primary endpoints: Pharmacokinetics of AP214 and Safety and Tolerability of AP214. Started May 2009; status: completed.
02
Drugs
modimelanotide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00903604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903604.